» Articles » PMID: 22166493

TNFα Increases Hypothalamic PTP1B Activity Via the NFκB Pathway in Rat Hypothalamic Organotypic Cultures

Overview
Journal Regul Pept
Specialty Biochemistry
Date 2011 Dec 15
PMID 22166493
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In obesity, levels of tumor necrosis-factor α (TNFα) are well known to be elevated in adipose tissues or serum, and a high-fat diet (HFD) reportedly increases TNFα expression in the hypothalamus. The expression levels of hypothalamic protein tyrosine phosphatase 1B (PTP1B), a negative regulator of leptin and insulin signaling, are also elevated by HFD, and several lines of evidence support a relationship between TNFα and PTP1B. It remains unclear however how TNFα acts locally in the hypothalamus to regulate hypothalamic PTP1B expression and activity. In this study, we examined whether TNFα can regulate PTP1B expression and activity using rat hypothalamic organotypic cultures. Incubation of cultures with TNFα resulted in increases in mRNA expression, protein levels and activity of PTP1B in a dose- and time-dependent manner, respectively compared with controls. TNFα-induced PTP1B protein levels were not influenced by co-incubation with the sodium channel blocker tetrodotoxin, indicating that the action of TNFα is independent of action potentials. TNFα also increased phosphorylation of p65, a subunit of nuclear factor-κB (NFκB), in a dose- and time-dependent manner. While incubation with inhibitors of NFκB did not affect basal levels of either p65 phosphorylation or PTP1B expression, it markedly suppressed both TNFα-induced p65 phosphorylation and PTP1B expression to almost basal levels. These data suggest that TNFα acts on the hypothalamus to increase hypothalamic PTP1B expression and activity via the NFκB pathway, and that TNFα-mediated induction of NFκB in the hypothalamus may cause leptin and insulin resistance in the hypothalamus by increasing hypothalamic PTP1B activity.

Citing Articles

Metformin ameliorates olanzapine-induced obesity and glucose intolerance by regulating hypothalamic inflammation and microglial activation in female mice.

Suh S, Lee N, Kim J, Kim S, Jang S, Park J Front Pharmacol. 2022; 13:906717.

PMID: 36313357 PMC: 9596779. DOI: 10.3389/fphar.2022.906717.


Regulation of Nrf2 and NF-κB activities may contribute to the anti-inflammatory mechanism of xylopic acid.

Boakye Y, Osafo N, Oppong-Kyekyeku J, Abotsi W, Boakye-Gyasi E, Heiss E Inflammopharmacology. 2022; 30(5):1835-1841.

PMID: 35260973 DOI: 10.1007/s10787-022-00950-y.


A Bridge Between and Studies in Neuroscience: Organotypic Brain Slice Cultures.

Alaylioglu M, Dursun E, Yilmazer S, Ak D Noro Psikiyatr Ars. 2020; 57(4):333-337.

PMID: 33354128 PMC: 7735142. DOI: 10.29399/npa.26139.


The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response.

Lee S, Kim S, Kang H, Lim H, Kwon Y, Jo M J Neuroinflammation. 2020; 17(1):299.

PMID: 33054766 PMC: 7556969. DOI: 10.1186/s12974-020-01963-6.


Does elevated bilirubin aid weight control by preventing development of hypothalamic leptin resistance?.

DiNicolantonio J, McCarty M, OKeefe J Open Heart. 2019; 6(1):e000897.

PMID: 30997121 PMC: 6443125. DOI: 10.1136/openhrt-2018-000897.